MAGL-IN-4
CAS No. 2135785-20-3
MAGL-IN-4 ( His121 ARG57 )
Catalog No. M28832 CAS No. 2135785-20-3
MAGL-IN-4 is one of the monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 356 | Get Quote |
|
10MG | 530 | Get Quote |
|
25MG | 851 | Get Quote |
|
50MG | 1152 | Get Quote |
|
100MG | 1557 | Get Quote |
|
500MG | 3114 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMAGL-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionMAGL-IN-4 is one of the monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases.
-
DescriptionMAGL-IN-4 is one of the monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases.(In Vitro):MAGL-IN-4 showed potent in vitro MAGL inhibitory activity (IC50 6.2 nM), good oral absorption and blood-brain barrier penetration.(In Vivo):MAGL-IN-4 showed significant pharmacodynamic changes (2-arachidonoylglycerol increase and arachidonic acid decrease) at 0.3-10 mg/kg, po. in mice.
-
SynonymsHis121 ARG57
-
PathwayMetabolic Enzyme/Protease
-
TargetLipase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2135785-20-3
-
Formula Weight364.8
-
Molecular FormulaC18H21ClN2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC1)N[C@@]21C[C@@H](C(N3CC(OCC4=CC=C(C)C(Cl)=C4)C3)=O)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jatczak, K., et al. Preparation of selectively protected protoescigenin derivatives for synthesis of escin analogs and neoglycoconjugates. cent.eur.j.chem. 12, 1222–1231 (2014).
molnova catalog
related products
-
Naftopidil DiHCl
Naftopidil DiHCl is a selective 5-HT1A and α1-adrenergic receptor antagonist with IC50 of 0.1 μM and 0.2 μM, respectively.
-
Atglistatin
Atglistatin is a highly potent, selective and competitive inhibitor of adipose triglyceride lipase (ATGL) with anIC50of ~0.7 μM for inhibition of lipolysis in vitro, but no toxicity up to a concentration of 50 μM.
-
MAGL-IN-4
MAGL-IN-4 is one of the monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases.